Dealmakers work on acquisition of neonatal monitoring specialist

12 November 2018

For our client we have worked on Lifelines Neurodiagnostic Systems’ acquisition of Incereb, an Irish business behind a range of sensors and monitors used in neonatal intensive care. Incereb becomes a sister company to Hampshire-based Lifelines Ltd.

The acquisition of Incereb, whose products include the neon neonatal EEG electrode array, will allow Lifelines Neurodiagnostic Systems to further develop its international offering of neurodiagnostic equipment.

The buyer plans to increase Incereb's R&D spend on a new product pipeline, and thereby grow into new markets and product lines. The transaction also means the buyer will retain a foothold in the EU post-Brexit, which was said to be an important consideration in making the purchase.

Simon Griffin, Chief Executive of Lifelines Neurodiagnostic Systems, said:

"We have been working with Incereb for several years in the US market, and their neon product is a perfect fit with our technology and growth plans. We are very excited not only to work with Jim Roche and Incereb on new product development, but also with the INFANT Centre at University College Cork and the fantastic research being performed there under the stewardship of Professor Geraldine Boylan."

The acquisition involved 27 sellers and included public sector bodies and institutional investors.

Barlow Robbins’ team was led by Tim Matthews and Mark Lucas, with assistance from Matthew Devine in the Corporate and Commercial team.

Mark Lucas, Head of Corporate and Commercial at Barlow Robbins, said:

"We were delighted to assist the Lifelines team with another acquisition and are excited to see their continued growth in the global neurodiagnostics field."

For further advice on the above topics, please call us on 01483 543210 or alternatively email